Addex

Addex is a Switzerland-based pharmaceutical company that develops and commercializes small molecule drugs for the treatment of neurological disorders.

Business Model:

Revenue: $1.1M

Employees: 11-50

Detailed Addex Information

Geographic Data

Addex headquarters map

Address: Chemin des Mines, 9

City: Plan-les-Ouates

State: geneva

Zip: 1202

Country: CH

Financial Info

Stage:

post ipo equity

Raised Last:

$4M

Raised Total:

$143M

Metrics

3,597,600Website Global Rank

3,742Website Monthly Traffic

Twitter Followers

Description

Addex is a Switzerland-based pharmaceutical company that develops and commercializes small molecule drugs for the treatment of neurological disorders.

Contact Phone:

Contact Email:

Addex went public on 5/21/2007 on the SIX Swiss Exchange

Listed Exchange:
SIX Swiss Exchange

IPO Date:
5/21/2007

Ticker Symbol:
ADXN 

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2013 Grant 1 $1M Michael J. Fox Foundation
Michael J. Fox Foundation
9/2018 Post-IPO Equity $1.6M Wellcome Trust.
5/2004 Series B $0 EDBI
Index Ventures
Initiative Capital
PolyTechnos Venture Partners
Renaissance
Sofinnova Partners
Techno Venture Management
VINCI CAPITAL
EDBI
Index Ventures
Initiative Capital
PolyTechnos Venture Partners
Renaissance
Sofinnova Partners
Techno Venture Management
VINCI CAPITAL
3/2015 Private Placement $2.6M
12/2021 Post-IPO Equity $10M Armistice Capital
2/2017 Post-IPO Equity $3M Herculis Partners SA
9/2010 Post-IPO Equity 1 $19.9M Biotechnology Value Fund
Biotechnology Value Fund
1/2017 Grant 1 $835k Michael J. Fox Foundation
Michael J. Fox Foundation
Michael J. Fox Foundation
Michael J. Fox Foundation
7/2002 Series A 3 $9.9M Techno Venture Management
Sofinnova Partners
Index Ventures
Techno Venture Management
Sofinnova Partners
Index Ventures
10/2017 Grant 1 $5.3M National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA)
7/2022 Post-IPO Equity 1 $4.2M Armistice Master Fund LTV
Armistice Master Fund LTV
8/2013 Post-IPO Equity 2 $3.5M Armistice Capital
Biotechnology Value Fund
Armistice Capital
Biotechnology Value Fund
2/2017 Post-IPO Equity 2 $3M New Enterprise Associates
Hercules Bioventure Partners
Hercules Bioventure Partners
New Enterprise Associates
Hercules Bioventure Partners
Hercules Bioventure Partners
10/2012 Post-IPO Equity $10.3M
9/2006 Series C $0 EDBI
Index Ventures
PolyTechnos Venture Partners
Renaissance
Roche Venture Fund
Sofinnova Partners
SR One
Varuma
EDBI
Index Ventures
PolyTechnos Venture Partners
Renaissance
Roche Venture Fund
Sofinnova Partners
SR One
Varuma
7/2021 Post-IPO Equity $0 Indivior
Indivior
3/2018 Post-IPO Equity $41.8M
3/2015 Post-IPO Equity 1 $2.8M Hercules Bioventure Partners
Hercules Bioventure Partners
8/2020 Grant 1 - InnoSuisse
InnoSuisse
1/2021 Post-IPO Equity $11.5M
7/2021 Post-IPO Equity 1 $4M Indivior
Indivior
8/2020 Grant 1 - InnoSuisse
InnoSuisse
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research